Read More Pharma Industry News Janssen to acquire skin disease drug candidate bermekimab from XBiotech Janssen Biotech acquisition of bermekimab: Janssen Biotech, a Janssen Pharmaceutical Company of Johnson & Johnson, has agreed to… bypharmanewsdailyDecember 8, 2019